Tag Archives: FDA

New Research Finds an Increased Risk of Osteoporosis and Bone Fractures from Antidepressants

Posted on March 17, 2025 by cchrstl

New study indicates that osteoporosis and bone fractures are significant potential risks of using antidepressants.  Citizens Commission on Human Rights calls on the U.S. Food and Drug Administration to update antidepressants prescribing information and medication guides to reflect these research findings and raise awareness. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , | Comments Off on New Research Finds an Increased Risk of Osteoporosis and Bone Fractures from Antidepressants

New Study Finds Antipsychotic Drugs Worsen Behavior in Nursing Home Residents

Posted on December 23, 2024 by cchrstl

New research provides additional evidence that off-label prescribing of antipsychotic drugs for elderly patients with dementia is not effective in reducing behavioral symptoms and exposes them to risks of serious side effects. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on New Study Finds Antipsychotic Drugs Worsen Behavior in Nursing Home Residents

CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

Posted on November 25, 2024 by cchrstl

Withdrawal symptoms are experienced by nearly half of the people trying to quit antidepressants, even if tapered over several weeks, research finds. CCHR says prescribing information and medication guides do not adequately convey this widespread risk and calls on FDA to require updates. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , | Comments Off on CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

Posted on November 18, 2024 by cchrstl

New research finds antidepressants increase the risk of stroke, atrial fibrillation, heart failure and other cardiovascular events. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

CCHR Calls on FDA to Revise Guidance on Use of Antidepressants by Pregnant Women

Posted on November 11, 2024 by cchrstl

Recent research adds to medical literature indicating potential risks to newborns from pregnant women using antidepressants. Citizens Commission on Human Rights calls on the U.S. Food and Drug Administration to review the research and issue updated guidance. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on CCHR Calls on FDA to Revise Guidance on Use of Antidepressants by Pregnant Women

Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Posted on October 28, 2024 by cchrstl

Decades after sexual dysfunction caused by antidepressants was first reported to persist after patients stopped taking the drugs, how many people experience continuing sexual problems is still not known.  Citizens Commission on Human Rights calls on the FDA to address the issue without further delay.  Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Clozapine (Really?) for Schizophrenia

Posted on October 21, 2024 by cchrstl

Psychiatric drugs and psychiatric treatments are not workable. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on Clozapine (Really?) for Schizophrenia

New Study Warns of High Dose “ADHD” Drugs Inducing Psychosis

Posted on October 14, 2024 by cchrstl

CCHR has documented psychosis and violent behavior linked to any dose of the drugs and wants them prohibited as a treatment for the 3.1 million American children put at risk by taking them. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on New Study Warns of High Dose “ADHD” Drugs Inducing Psychosis

CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

Posted on September 2, 2024 by cchrstl

Evidence presented to the U.S. drug regulatory agency alleging sexual assault and suppression of adverse events in clinical trials of ecstasy raises urgent concerns about the safety of patients in psychedelic-assisted psychotherapy. Citizens Commission on Human Rights calls for public release of FDA investigation results. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

Posted on August 19, 2024 by cchrstl

The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted three MDMA therapy research papers for ethical violations. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , | Comments Off on CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients